ChronoScale Corporation Common Stock (NASDAQ:CHRN) Sees Significant Decrease in Short Interest

ChronoScale Corporation Common Stock (NASDAQ:CHRN) saw a large decline in short interest in the month of July. As of July 31st, there was short interest totaling 598,565 shares, a decline of 49.4% from the July 15th total of 1,182,882 shares. Approximately 18.0% of the shares of the company are short sold. Based on an average daily trading volume, of 281,263 shares, the short-interest ratio is currently 2.1 days.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. J.Safra Asset Management Corp acquired a new stake in shares of ChronoScale Corporation Common Stock in the second quarter valued at about $105,000. Osbon Capital Management LLC acquired a new position in ChronoScale Corporation Common Stock during the second quarter valued at approximately $81,000. Roble Belko & Company Inc boosted its position in ChronoScale Corporation Common Stock by 104.5% during the first quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock valued at $25,000 after purchasing an additional 1,195 shares during the last quarter. Philadelphia Investment Partners LLC bought a new position in ChronoScale Corporation Common Stock in the second quarter valued at approximately $589,000. Finally, Great Lakes Advisors LLC bought a new position in ChronoScale Corporation Common Stock in the second quarter valued at approximately $755,000. Institutional investors and hedge funds own 6.42% of the company’s stock.

ChronoScale Corporation Common Stock Stock Performance

CHRN stock traded up $1.26 during trading on Monday, reaching $22.19. 106,755 shares of the stock were exchanged, compared to its average volume of 249,123. ChronoScale Corporation Common Stock has a twelve month low of $3.01 and a twelve month high of $30.00. The company has a current ratio of 1.55, a quick ratio of 1.03 and a debt-to-equity ratio of 0.25. The company has a market capitalization of $79.06 million, a P/E ratio of -4.12 and a beta of 1.00. The stock has a 50 day simple moving average of $21.40 and a 200-day simple moving average of $15.27.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last issued its earnings results on Tuesday, June 30th. The company reported ($3.89) earnings per share (EPS) for the quarter. ChronoScale Corporation Common Stock had a negative return on equity of 197.81% and a negative net margin of 135.66%.The company had revenue of $18.09 million during the quarter. As a group, sell-side analysts anticipate that ChronoScale Corporation Common Stock will post -0.1 earnings per share for the current year.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.